WAI CHUN BIOTEC (00660) announced its annual results for the year ended June 30, 2025. The group recorded revenue of HK$377 million, representing a year-on-year increase of 1.92%. Loss attributable to owners of the company was HK$14.623 million, down 66.93% year-on-year. Loss per share was HK$0.0843. The announcement noted that the improvement in losses was primarily due to a significant reduction in impairment losses on non-financial assets during the reporting period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.